- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Emergent Biosolutions Inc (EBS)
Emergent Biosolutions Inc stock price live, this page displays NYSE EBS stock exchange data. View the EBS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Emergent Biosolutions Inc real time stock price chart below.
What Is the Emergent Biosolutions Inc Stock Price Today?
The Emergent Biosolutions Inc stock price today is 6.070.
What Is the Stock Symbol for Emergent Biosolutions Inc?
The stock symbol for Emergent Biosolutions Inc is ""EBS.""
What Stock Exchange Does Emergent Biosolutions Inc Trade On?
Emergent Biosolutions Inc is listed and trades on the NYSE stock exchange.
Is Emergent Biosolutions Inc a Good Stock to Buy?
Determining whether Emergent Biosolutions Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EBS quote. (ISIN: US29089Q1058)
What Is the Emergent Biosolutions Inc Stock Price Today?
The Emergent Biosolutions Inc stock price today is 6.070.
What Is the Stock Symbol for Emergent Biosolutions Inc?
The stock symbol for Emergent Biosolutions Inc is ""EBS.""
What Stock Exchange Does Emergent Biosolutions Inc Trade On?
Emergent Biosolutions Inc is listed and trades on the NYSE stock exchange.
Is Emergent Biosolutions Inc a Good Stock to Buy?
Determining whether Emergent Biosolutions Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EBS quote. (ISIN: US29089Q1058)
6.070
-0.430(-6.62%)
Closed·
After Hours
6.240+0.170(+2.80%)
·
Fair Value
An estimate of a Emergent Biosolutions's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.985
6.640
52 wk Range
4.020
13.275
EBS Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 6 days
More Info
Fair Value
An estimate of a Emergent Biosolutions's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.9856.640
52 wk Range
4.02013.275
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EBS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Emergent Biosolutions's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
13.500
Upside
+122.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Emergent Biosolutions Inc Company Profile
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; Botulism Antitoxin Heptavalent for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Trobigard, an atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Emergent Biosolutions Inc Earnings Call Summary for Q1/2025
- Net income surged 656% to $68 million, despite revenue decline to $222 million; stock rose 17.51% in aftermarket trading
- Adjusted EBITDA margin improved by 1,300 basis points to 35%; adjusted gross margin up 700 basis points to 58%
- NARCAN nasal spray maintained market leadership; naloxone market expected to grow mid-single-digit unit volumes
- Strategic divestitures and restructuring reduced operating expenses by 32%; net leverage decreased to 2.8x adjusted EBITDA
- 2025 guidance: revenue $750-850 million, adjusted EBITDA $150-200 million; expansion planned in EU, Middle East, Africa, Asia Pacific
Last Updated: 07/05/2025, 23:28
Read Full TranscriptCompare EBS to Peers and Sector
Metrics to compare | EBS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEBSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.5x | −3.9x | −0.5x | |
PEG Ratio | −0.03 | −0.22 | 0.00 | |
Price/Book | 0.6x | 2.2x | 2.6x | |
Price / LTM Sales | 0.3x | 18.3x | 3.3x | |
Upside (Analyst Target) | 122.4% | 181.2% | 42.4% | |
Fair Value Upside | Unlock | 0.5% | 7.2% | Unlock |
Analyst Ratings
2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13.500
(+122.41% Upside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
0.71 / 0.49
Revenue / Forecast
222.20M / 279.00M
People Also Watch
FAQ
What Stock Exchange Does Emergent Biosolutions Trade On?
Emergent Biosolutions is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Emergent Biosolutions?
The stock symbol for Emergent Biosolutions is "EBS."
What Is the Emergent Biosolutions Market Cap?
As of today, Emergent Biosolutions market cap is 329.47M.
What Is Emergent Biosolutions's Earnings Per Share (TTM)?
The Emergent Biosolutions EPS (TTM) is -2.46.
When Is the Next Emergent Biosolutions Earnings Date?
Emergent Biosolutions will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is EBS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Emergent Biosolutions Stock Split?
Emergent Biosolutions has split 0 times.
How Many Employees Does Emergent Biosolutions Have?
Emergent Biosolutions has 900 employees.
What is the current trading status of Emergent Biosolutions (EBS)?
As of 31 Jul 2025, Emergent Biosolutions (EBS) is trading at a price of 6.07, with a previous close of 6.07. The stock has fluctuated within a day range of 5.99 to 6.64, while its 52-week range spans from 4.02 to 13.28.
What Is Emergent Biosolutions (EBS) Price Target According to Analysts?
The average 12-month price target for Emergent Biosolutions is USD13.5, with a high estimate of USD15 and a low estimate of USD12. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +122.41% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.